Hanson McClain Advisors »

Peregrine Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0k 455 6.70
2023-12-31 $3.0k 455 6.50
2023-09-30 $274 29 9.45
2023-06-30 $406 29 14.00
2023-03-31 $1.7k 91 18.77
2022-12-31 $398 29 13.76
2022-09-30 $1.0k 29 34.48
2022-06-30 $11k 715 15.38
2022-03-31 $15k 715 20.98
2021-12-31 $21k 715 29.37
2021-09-30 $15k 686 21.87
2021-06-30 $18k 686 26.24
2021-03-31 $13k 686 18.95
2020-12-31 $8.0k 686 11.66
2020-09-30 $5.0k 686 7.29
2020-06-30 $5.0k 686 7.29
2020-03-31 $4.0k 686 5.83
2019-12-31 $5.0k 686 7.29
2019-09-30 $4.0k 686 5.83
2019-06-30 $4.0k 686 5.83
2019-03-31 $3.0k 686 4.37
2018-12-31 $3.0k 686 4.37
2018-09-30 $5.0k 686 7.29
2018-06-30 $3.0k 686 4.37
2018-03-31 $2.0k 686 2.92